Dexcom Q1 revenue beats on international growth

DexCom

30/04/2026 21:10

Overview

U.S. glucose monitoring device maker's Q1 revenue rose 15%, beating analyst expectations

Adjusted EPS for Q1 beat analyst expectations

Growth driven by demand for Dexcom CGM and expanded G7 15 Day launch in U.S.

Outlook

Dexcom sees 2026 revenue of $5.16-$5.25 bln, about 11-13% growth

Company expects 2026 non-GAAP gross profit margin of about 63-64%

Dexcom raises 2026 non-GAAP operating margin outlook to about 23-23.5%

Result Drivers

INTERNATIONAL GROWTH - Co said international revenue grew 26% year-over-year on a reported basis, outpacing U.S. growth

PRODUCT LAUNCH - Expanded launch of Dexcom G7 15 Day CGM across all channels in the United States supported revenue growth

OPERATIONAL IMPROVEMENT - Co cited continued operational improvement as contributing to margin expansion

Company press release: ID:nBwbrCc9na

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$1.19 bln
$1.17 bln (22 Analysts)
Q1 Adjusted EPS
Beat
$0.56
$0.47 (23 Analysts)
Q1 Adjusted Net Income
Beat
$216.30 mln
$184.32 mln (18 Analysts)
Q1 Adjusted Operating Income
Beat
$264.40 mln
$218.17 mln (21 Analysts)
Q1 Adjusted Gross Profit
$757.40 mln
Q1 Gross Profit
$750.30 mln
Q1 Operating Income
$255.30 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 27 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Dexcom Inc is $85.00, about 47.7% above its April 29 closing price of $57.56

The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 27 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)